{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:58:51Z","timestamp":1781153931290,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008211","name":"Association France Parkinson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008211","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.curtheres.2026.100830","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:38:53Z","timestamp":1775230733000},"page":"100830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Healthcare Providers\u2019 Acceptability of Cannabis And Cannabidiol to Manage Parkinson\u2019s Disease in France"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3439-8868","authenticated-orcid":false,"given":"Tangui","family":"Barr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Cazorla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Di Beo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Baunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2026.100830_bib0001","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/cns.13549","article-title":"Quality of life in Parkinson\u2019s disease: a systematic review and meta-analysis of comparative studies","volume":"27","author":"Zhao","year":"2020","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.curtheres.2026.100830_bib0002","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mdc3.13262","article-title":"Progression in Parkinson\u2019s Disease: variation in motor and non-motor symptoms severity and predictors of decline in cognition, motor function, disability, and health-related quality of life as assessed by two different methods","volume":"8","author":"Bugalho","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.curtheres.2026.100830_bib0003","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/mds.21667","article-title":"Quality of life in Parkinson\u2019s disease: the relative importance of the symptoms","volume":"23","author":"Rahman","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.curtheres.2026.100830_bib0004","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","article-title":"What contributes to quality of life in patients with Parkinson\u2019s disease?","volume":"69","author":"Schrag","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.curtheres.2026.100830_bib0005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.curtheres.2026.100830_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ncl.2008.05.003","article-title":"Adverse events from the treatment of Parkinson\u2019s disease","volume":"26","author":"Chou","year":"2008","journal-title":"Neurol Clin"},{"key":"10.1016\/j.curtheres.2026.100830_bib0007","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-57369-0_1","article-title":"Constituents of cannabis sativa","volume":"1264","author":"Rock","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.curtheres.2026.100830_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072348","article-title":"Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies","volume":"382","author":"Solmi","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.curtheres.2026.100830_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109745","article-title":"The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson\u2019s disease","volume":"96","author":"Han","year":"2020","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.curtheres.2026.100830_bib0010","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1007\/s12035-020-02054-6","article-title":"Current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson\u2019s and Alzheimer\u2019s diseases: a review","volume":"57","author":"Cooray","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.curtheres.2026.100830_bib0011","article-title":"Effects of cannabis in Parkinson\u2019s Disease: a systematic review and meta-analysis","author":"Urbi","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.curtheres.2026.100830_bib0012","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00702-022-02529-x","article-title":"Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review","volume":"129","author":"Oikonomou","year":"2022","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.curtheres.2026.100830_bib0013","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/can.2023.0023","article-title":"Cannabinoids in treating Parkinson\u2019s Disease symptoms: a systematic review of Clinical studies","volume":"8","author":"Varshney","year":"2023","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.curtheres.2026.100830_bib0014","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.29498","article-title":"Cognitive safety of cannabis products in Parkinson\u2019s Disease: need for solid scientific evidence to guide clinicians and patients currently on shaky grounds","volume":"38","author":"Turner","year":"2023","journal-title":"Mov Disord"},{"key":"10.1016\/j.curtheres.2026.100830_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29768","article-title":"Short-term cannabidiol with \u0394-9-tetrahydrocannabinol in Parkinson\u2019s disease: a randomized trial","author":"Liu","year":"2024","journal-title":"Mov Disord"},{"key":"10.1016\/j.curtheres.2026.100830_bib0016","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/ane.13602","article-title":"Cannabis use in Parkinson\u2019s disease\u2014a nationwide online survey study","volume":"145","author":"Erga","year":"2022","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.curtheres.2026.100830_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/874849","article-title":"Self-reported efficacy of cannabis and other complementary medicine modalities by Parkinson\u2019s disease patients in colorado","volume":"2015","author":"Finseth","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.curtheres.2026.100830_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41531-021-00165-y","article-title":"Weeding through the haze: a survey on cannabis use among people living with Parkinson\u2019s disease in the US","volume":"7","author":"Feeney","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.curtheres.2026.100830_bib0019","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JPD-202260","article-title":"Cannabis in Parkinson\u2019s disease: the patients\u2019 view","volume":"11","author":"Yenilmez","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.curtheres.2026.100830_bib0020","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/mds.20111","article-title":"Survey on cannabis use in Parkinson\u2019s disease: subjective improvement of motor symptoms","volume":"19","author":"Venderov\u00e1","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.curtheres.2026.100830_bib0021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ctim.2017.07.002","article-title":"Cannabis use in people with Parkinson\u2019s disease and multiple sclerosis: a web-based investigation","volume":"33","author":"Kindred","year":"2017","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.curtheres.2026.100830_bib0022","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2020.06.033","article-title":"Cannabis in patients with Parkinson\u2019s disease in Argentina. A cross sectional study","volume":"78","author":"Micheli","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.curtheres.2026.100830_bib0023","first-page":"61","article-title":"Delta-9-tetrahydrocannabinol and cannabidiol drug-drug interactions","volume":"3","author":"Kocis","year":"2020","journal-title":"MCA"},{"key":"10.1016\/j.curtheres.2026.100830_bib0024","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/dar.12823","article-title":"Perceived support for medical cannabis use among approved medical cannabis users in Canada","volume":"37","author":"Leos-Toro","year":"2018","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.curtheres.2026.100830_bib0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.drugpo.2014.02.009","article-title":"Barriers to access for Canadians who use cannabis for therapeutic purposes","volume":"25","author":"Belle-Isle","year":"2014","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.curtheres.2026.100830_bib0026","doi-asserted-by":"crossref","DOI":"10.9778\/cmajo.20200187","article-title":"Attitudes toward medical cannabis among family physicians practising in Ontario, Canada: a qualitative research study","volume":"9","author":"Ng","year":"2021","journal-title":"CMAJ Open"},{"key":"10.1016\/j.curtheres.2026.100830_bib0027","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12875-021-01559-w","article-title":"Physicians\u2019 experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review","volume":"22","author":"R\u00f8nne","year":"2021","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.curtheres.2026.100830_bib0028","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mdc3.12359","article-title":"Medicinal cannabis for Parkinson\u2019s disease: practices, beliefs, and attitudes among providers at National Parkinson Foundation Centers of Excellence","volume":"4","author":"Bega","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.curtheres.2026.100830_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216556","article-title":"Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis \u2013 a systematic review","volume":"14","author":"Gardiner","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.curtheres.2026.100830_bib0030","article-title":"Clinician beliefs and practices related to cannabis","author":"Schauer","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.curtheres.2026.100830_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107102","article-title":"Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists","volume":"109","author":"Szaflarski","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.curtheres.2026.100830_bib0032","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/papr.13161","article-title":"Healthcare professionals\u2019 perspectives on the use of medicinal cannabis to manage chronic pain: a systematic search and narrative review","volume":"22","author":"Cheng","year":"2022","journal-title":"Pain Pract"},{"key":"10.1016\/j.curtheres.2026.100830_bib0033","doi-asserted-by":"crossref","DOI":"10.1111\/ijn.12836","article-title":"The effect of attitudes, subjective norms and stigma on health-care providers\u2019 intention to recommend medicinal cannabis to patients","volume":"27","author":"Melnikov","year":"2021","journal-title":"Int J Nurs Pract"},{"key":"10.1016\/j.curtheres.2026.100830_bib0034","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/dar.13547","article-title":"Exploring the medical cannabis prescribing behaviours of French general practitioners","volume":"42","author":"Barr\u00e9","year":"2023","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.curtheres.2026.100830_bib0035","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1177\/1477370820983560","article-title":"Cannabis users and stigma: a comparison of users from European countries with different cannabis policies","volume":"19","author":"Skliamis","year":"2022","journal-title":"Eur J Criminol"},{"key":"10.1016\/j.curtheres.2026.100830_bib0036","doi-asserted-by":"crossref","DOI":"10.1177\/10497323241227419","article-title":"The effects of stigma: older persons and medicinal cannabis","author":"Dahlke","year":"2024","journal-title":"Qual Health Res"},{"key":"10.1016\/j.curtheres.2026.100830_bib0037","doi-asserted-by":"crossref","DOI":"10.1177\/21501319251394522","article-title":"Primary care physicians\u2019 knowledge and counseling on cannabis use in the country of Georgia: results of a mixed-method exploratory study","volume":"16","author":"Nadiradze","year":"2025","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.curtheres.2026.100830_sbref0038","series-title":"Cadre et mise en oeuvre de l\u2019exp\u00e9rimentation (Framework and implementation of the experimentation)","year":"2021"},{"key":"10.1016\/j.curtheres.2026.100830_bib0039","doi-asserted-by":"crossref","DOI":"10.5603\/PJNNS.a2022.0004","article-title":"Cannabis in Parkinson\u2019s Disease - the patient\u2019s perspective versus clinical trials: a systematic literature review","author":"Figura","year":"2022","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.curtheres.2026.100830_bib0040","article-title":"Patterns of use and patient-reported effects of cannabinoids in people with PD: a nationwide survey","volume":"2025","author":"Barr\u00e9","year":"2025","journal-title":"Parkinson\u2019s Disease"},{"key":"10.1016\/j.curtheres.2026.100830_bib0041","series-title":"MILDECA | Le CBD","year":"2025"},{"key":"10.1016\/j.curtheres.2026.100830_bib0042","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1186\/s12889-022-14057-0","article-title":"Cannabidiol use and perceptions in France: a national survey","volume":"22","author":"Casanova","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.curtheres.2026.100830_bib0043","doi-asserted-by":"crossref","DOI":"10.1111\/dar.13842","article-title":"Cannabidiol use in France in 2022: results from a nationwide representative sample of adults","author":"Barr\u00e9","year":"2024","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.curtheres.2026.100830_bib0044","article-title":"Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson\u2019s disease: a French survey","volume":"11","author":"Barr\u00e9","year":"2024","journal-title":"Clin Park Relat Disord"},{"key":"10.1016\/j.curtheres.2026.100830_bib0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.curtheres.2026.100830_bib0046","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.curtheres.2026.100830_bib0047","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29447","article-title":"Cognitive safety data from a randomized, double-blind, parallel-group, Placebo-controlled Phase IIb study of the effects of a cannabidiol and \u03949-tetrahydrocannabinol drug on Parkinson\u2019s disease-related motor symptoms","author":"Domen","year":"2023","journal-title":"Mov Disord"},{"issue":"24","key":"10.1016\/j.curtheres.2026.100830_bib0048","article-title":"Assessment of education in a community hospital on healthcare providers\u2019 knowledge of and attitudes toward medical marijuana","volume":"S1877-1297","author":"Meyers","year":"2024","journal-title":"Curr Pharm Teach Learn"},{"key":"10.1016\/j.curtheres.2026.100830_bib0049","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/15563650.2015.1004581","article-title":"Change in perceived risk associated with marijuana use in the United States from 2002 to 2012","volume":"53","author":"Okaneku","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.curtheres.2026.100830_bib0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.drugalcdep.2015.02.009","article-title":"Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race\/ethnicity","volume":"149","author":"Pacek","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.curtheres.2026.100830_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2021.107091","article-title":"Age-varying time trends in cannabis- and alcohol-related risk perceptions 2002-2019","volume":"124","author":"Waddell","year":"2022","journal-title":"Addict Behav"},{"key":"10.1016\/j.curtheres.2026.100830_bib0052","article-title":"Gender differences in the support of medical marijuana use among primary care providers","volume":"5","author":"Polak","year":"2024","journal-title":"Womens Health Rep"},{"key":"10.1016\/j.curtheres.2026.100830_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.encep.2023.04.006","article-title":"French general practitioners and medical cannabis: a need for training","author":"Barr\u00e9","year":"2023","journal-title":"L\u2019Enc\u00e9phale"},{"key":"10.1016\/j.curtheres.2026.100830_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111263","article-title":"The prevalence of cannabis use disorders in people who use medicinal cannabis: a systematic review and meta-analysis","volume":"257","author":"Dawson","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.curtheres.2026.100830_bib0055","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/0269881120986393","article-title":"Cannabis based medicines and cannabis dependence: a critical review of issues and evidence","volume":"35","author":"Schlag","year":"2021","journal-title":"J Psychopharmacol (Oxford, England)"},{"key":"10.1016\/j.curtheres.2026.100830_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.jflm.2025.102947","article-title":"Medical cannabis: regulatory review in United States, European Union and United Kingdom","volume":"115","author":"Arjun","year":"2025","journal-title":"J Forensic Leg Med"},{"key":"10.1016\/j.curtheres.2026.100830_bib0057","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1089\/can.2021.0061","article-title":"Ask your provider about cannabis: increasing nurse practitioner knowledge and confidence","volume":"7","author":"Klein","year":"2022","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.curtheres.2026.100830_bib0058","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejim.2018.01.001","article-title":"Medical use of cannabis and cannabinoids containing products - regulations in Europe and North America","volume":"49","author":"Abuhasira","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.curtheres.2026.100830_bib0059","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1002\/ptr.7232","article-title":"The emerging role of cannabidiol (CBD) products; a survey exploring the public\u2019s use and perceptions of CBD","volume":"35","author":"Bhamra","year":"2021","journal-title":"Phytother Res"},{"key":"10.1016\/j.curtheres.2026.100830_bib0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.9740\/mhc.2023.10.217","article-title":"Consumer perception, knowledge, and uses of cannabidiol","volume":"13","author":"Nguyen","year":"2023","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.curtheres.2026.100830_bib0061","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/02791072.2021.2009598","article-title":"Attitudes toward the use of medical cannabis and the perceived efficacy, side-effects and risks: a survey of patients, nurses and physicians","volume":"54","author":"HaGani","year":"2022","journal-title":"J Psychoactive Drugs"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X26000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X26000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:22:08Z","timestamp":1781151728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X26000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":61,"alternative-id":["S0011393X26000111"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2026.100830","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healthcare Providers\u2019 Acceptability of Cannabis And Cannabidiol to Manage Parkinson\u2019s Disease in France","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2026.100830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100830"}}